Living Well
Commercial- Indications
- Cancer-related mental health support
Company intelligence / Profile preview
Prosoma has developed "Living Well" and "Living Well Plus," CE-marked digital therapeutic platforms providing behavioral and psychological support to cancer patients. Clinical studies show these programs reduce anxiety, stress, and depression by up to 25–50% among users. The solution will be reimbursed under Germany's DiGA program. Over 2,500+ patients supported as of early 2025.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Prosoma.